Clinical trial
Biological Therapy in Treating Patients With Metastatic Cancer
NCT00002733 · Hoag Memorial Hospital Presbyterian, Other · Completed
Key facts
| NCT number | NCT00002733 |
|---|---|
| Title | Biological Therapy in Treating Patients With Metastatic Cancer |
| Official title | ALPHA INTERFERON, TUMOR INFILTRATING LYMPHOCYTES, AND INTERLEUKIN-2 IN THE TREATMENT OF CANCER |
| Lead sponsor | Hoag Memorial Hospital Presbyterian, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer, Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug |
| Interventions | aldesleukin, recombinant interferon alfa, therapeutic tumor infiltrating lymphocytes, cimetidine |
| Enrollment | 30 |
| Start date | Jan 1, 1996 |
| Primary completion | Jan 1, 2000 |
| Completion | Jan 1, 2000 |
| First posted | Jul 1, 2004 |
| Last update posted | May 11, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: